Oxford-AstraZeneca’s COVID-19 vaccine experiment is tied to eugenics-linked institutions


A closer look at the developers behind the Oxford-AstraZeneca COVID-19 vaccine reveals previously undisclosed ties with eugenics-linked institutions such as the British Eugenics Society, the Jenner Institute, and the Wellcome Trust. One of the developers, Adrian Hill, is directly linked to the Galton Institute, which is connected to the U.K. Eugenics movement. For decades, these institutions have espoused belief in eliminating the most undesirable people from the population. Gruesomely, this experimental vaccine is being positioned for deployment in the most impoverished nations.

An investigation by the British Medical Journal found that the Jenner Institute knowingly misled South African parents about an experimental Tb vaccine, leading to the death of seven infants in 2009.

The eugenics-linked vaccine developer was working on a covid-19 vaccine before a pandemic was declared

In January 2020, Oxford Professor Andrew Pollard was given a tip by scientists working for the U.K.’s Scientific Advisory Group for Emergencies. The U.K. scientists shared that there would soon be a global pandemic and a gold-rush for suitable vaccines. Even though most of the world was told for months that “little is known about the virus,” Oxford’s Jenner Institute already had access to insider information and had already begun to develop a COVID-19 vaccine in mid-January, long before the World Health Organization declared a “worldwide pandemic.”

On April 30, 2020, AstraZeneca and Oxford University joined forces to develop and distribute that COVID-19 vaccine. The Oxford Vaccine Group and the Jenner Institute worked on vaccine development and research while AstraZeneca prepared to manufacture and distribute the vaccines. These entities were awarded an Operation Warp Speed contract less than a month later, which provided copious taxpayer funds for speedy vaccine development.

Brighteon.TV

There were serious issues with the rushed clinical trials, and these trials had to be paused on multiple occasions. The trials did not use a saline placebo. Instead, the study design used a troublesome vaccine as the placebo. The placebo vaccine exhibited a host of side effects that were comparable to the side effects of the coronavirus vaccine, skewing the data on its “safety.” The study design also mis-dosed some participants, skewing the self-reported efficacy rate of the new vaccine. The trial was also marred by the death of participants.

Despite these serious issues, the lead developer of the Oxford-AstraZeneca vaccine, Adrian Hill, went on NBC to pressure the FDA to approve the vaccine and rush it out onto the population. Hill said: “To wait for the end of the trial would be the middle of next year. That’s too late, this vaccine is effective, available at large scale and easily deployed.” (Related: As vaccine shipments arrive, Department of Veterans Affairs will target blacks and Hispanics first.)

Oxford vaccine developers looking to rule over the poor, coerce and subject them to experimental vaccines

The media has paraded the vaccine for months, claiming that it will save the poorest nations and be distributed to many millions of people in the developing world. Dr. Richard Horton, the editor-in-chief of the Lancet medical journal, who participated in the suppression of viable covid-19 treatments, told CNBC that “The Oxford AstraZeneca vaccine is the vaccine right now that is going to be able to immunize the planet more effectively, more rapidly than any other vaccine we have” in large part because it is a “vaccine that can get to lower middle-income countries.”

No media outlet has dared to mention the network of people who seek to profit off this vaccine swindle. No media outlet has dared to challenge the eugenics-linked institutions that are behind these coercive shutdowns and restrictions that are being carried out to force compliance with vaccine mandates.

Vaccitech is a private company behind the Oxford-AstraZeneca partnership. The main investors behind Vaccitech include former top Deutsche Bank executives, Google and the government of the United Kingdom. Adrian Hill and Sarah Gilbert, the vaccine’s two developers, own approximately 10 percent stake in the company and are trying to make the injection mandatory on an annual basis.

These two developers are directly linked to the Galton Institute and the Wellcome Trust, which are both connected to the U.K. Eugenics movement. The Galton Institute is derived from the U.K. Eugenics Society and is named after the “father of eugenics” – Francis Galton. These scientists are interested in one thing: depopulation, and they are in the position to reap profits for life, giving power and wealth to their lineage for generations to come. For over a century, these nefarious groups have worked to “improve racial stock” by reducing the number of ‘inferior’ people in the population.

The Oxford-AstraZeneca vaccine is being pushed on countries like those in Latin America, South and Southeast Asia and Africa, the precise locations where the Galton Institute has called for population reduction in the past. Adrian Hill’s ties to the Galton Institute are a major cause for concern. Google’s investment in this venture is just as creepy, especially with their artificial intelligence capabilities.

Learn more about the eugenics-vaccine connection at Eugenics.news.

Sources include:

GreatGameIndia.com

BMJ.com

NaturalNews.com

Well.uk


Submit a correction >>

Get Our Free Email Newsletter
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
Your privacy is protected. Subscription confirmation required.


Comments
comments powered by Disqus

Get Our Free Email Newsletter
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
Your privacy is protected. Subscription confirmation required.

RECENT NEWS & ARTICLES

Get the world's best independent media newsletter delivered straight to your inbox.
x

By continuing to browse our site you agree to our use of cookies and our Privacy Policy.